Literature DB >> 16443707

COPD exacerbations .1: Epidemiology.

G C Donaldson1, J A Wedzicha.   

Abstract

The epidemiology of exacerbations of chronic obstructive pulmonary disease (COPD) is reviewed with particular reference to the definition, frequency, time course, natural history and seasonality, and their relationship with decline in lung function, disease severity and mortality. The importance of distinguishing between recurrent and relapsed exacerbations is discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16443707      PMCID: PMC2104564          DOI: 10.1136/thx.2005.041806

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  39 in total

1.  Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline.

Authors:  L J Dowson; P J Guest; R A Stockley
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

2.  Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study.

Authors:  J Garcia-Aymerich; E Monsó; R M Marrades; J Escarrabill; M A Félez; J Sunyer; J M Antó
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

3.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

4.  Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  C M Roberts; D Lowe; C E Bucknall; I Ryland; Y Kelly; M G Pearson
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

5.  Respiratory viral infections in adults with and without chronic obstructive pulmonary disease.

Authors:  S B Greenberg; M Allen; J Wilson; R L Atmar
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

6.  Randomized controlled trial of supported discharge in patients with exacerbations of chronic obstructive pulmonary disease.

Authors:  E Skwarska; G Cohen; K M Skwarski; C Lamb; D Bushell; S Parker; W MacNee
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

7.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

8.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Authors:  R E Kanner; N R Anthonisen; J E Connett
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

9.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

Authors:  R A Stockley; C O'Brien; A Pye; S L Hill
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

10.  The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.

Authors:  A McGuire; D E Irwin; P Fenn; A Gray; P Anderson; A Lovering; A MacGowan
Journal:  Value Health       Date:  2001 Sep-Oct       Impact factor: 5.725

View more
  127 in total

1.  Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation.

Authors:  Jung-Wan Yoo; Yoonki Hong; Joon Beom Seo; Eun Jin Chae; Seung Won Ra; Ji-Hyun Lee; Eun Kyung Kim; Seunghee Baek; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Seung Soo Sheen; Jae Seung Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

Review 2.  Clinical review: Endobronchial valve treatment for emphysema.

Authors:  Nabil Jarad
Journal:  Chron Respir Dis       Date:  2016-02-15       Impact factor: 2.444

3.  What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.

Authors:  J R Hurst; J A Wedzicha
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

4.  Impairment of the swallowing reflex in exacerbations of COPD.

Authors:  Seiichi Kobayashi; Hiroshi Kubo; Masaru Yanai
Journal:  Thorax       Date:  2007-11       Impact factor: 9.139

5.  Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study.

Authors:  Arne Egesten; Lena Brandt; Tomas Olsson; Fredrik Granath; Malin Inghammar; Claes-Göran Löfdahl; Anders Ekbom
Journal:  Lung       Date:  2008-03-20       Impact factor: 2.584

6.  Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism.

Authors:  J A Wedzicha; J R Hurst
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

7.  Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; V N Maturu; Sahajal Dhooria; K T Prasad; Inderpaul S Sehgal; Lakshmikant B Yenge; Aditya Jindal; Navneet Singh; A G Ghoshal; G C Khilnani; J K Samaria; S N Gaur; D Behera
Journal:  Lung India       Date:  2013-07

8.  Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.

Authors:  Jason D Keene; Sean Jacobson; Katerina Kechris; Gregory L Kinney; Marilyn G Foreman; Claire M Doerschuk; Barry J Make; Jeffrey L Curtis; Stephen I Rennard; R Graham Barr; Eugene R Bleecker; Richard E Kanner; Eric C Kleerup; Nadia N Hansel; Prescott G Woodruff; MeiLan K Han; Robert Paine; Fernando J Martinez; Russell P Bowler; Wanda K O'Neal
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

9.  Clinical Features according to the Frequency of Acute Exacerbation in COPD.

Authors:  Seung Jun Lee; Seung Hun Lee; Yu Eun Kim; Yu Ji Cho; Yi Yeong Jeong; Ho Cheol Kim; Jin Hyun Kim; Jin Jong You; Chul-Ho Yoon; Jong Deog Lee; Young Sil Hwang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-04-30

Review 10.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.